Main Menu

CAS Medical Systems, Inc.

(NASDAQ CM: CASM)

Summary

Attention investors who purchased shares of CAS Medical Systems, Inc. before February 12, 2019:

Rigrodsky & Long is investigating potential claims against the board of directors of CAS Medical Systems, Inc. concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to be acquired by Edwards Lifesciences Corporation for approximately $100 million.

Press Release

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of CAS Medical Systems, Inc. (“CAS Medical” or the “Company”) (NASDAQ CM: CASM) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by Edwards Lifesciences Corporation (“Edwards Lifesciences”) (NYSE: EW) in a transaction valued at approximately $100 million.  Under the terms of the agreement, shareholders of CAS Medical will receive $2.45 in cash for each share of CAS Medical common stock.

If you own common stock of CAS Medical and purchased any shares before February 12, 2019, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra toll-free at (888) 969-4242, by e-mail at info@rl-legal.com, or at https://www.rigrodskylong.com/offices-contact.  

Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Back to Page